Five Prime's new CEO wields ax, laying off 70 staffers

Five Prime Therapeutics’ interim CEO William Ringo has moved to lay off 70 employees within weeks of taking up the position. The cuts will leave Five Prime with a “small research group” focused on taking clinical candidates forward with the help of service providers and contractors.